secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adicet Bio, Inc. (ACET)
CIK:        0001720580
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0000950170-25-054995
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adicet Bio appoints Michael Grissinger to Board; Carl Gordon resigns
--------------------------------------------------------------------

- Carl L. Gordon resigned from Board and Compensation Committee effective April 17, 2025; no disagreement with management.
- Michael Grissinger appointed to Board and Compensation Committee, effective April 17, 2025, as Class II director until 2026 annual meeting.
- Grissinger received option to purchase 70,200 shares at April 17 closing price, vesting over 36 months.
- Grissinger brings 40+ years pharma experience, including 20+ years at Johnson & Johnson leading immunology licensing and M&A.
- He also serves on boards of Aprea Therapeutics (APRE) and three private biotechs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720580/000095017025054995/0000950170-25-054995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720580/000095017025054995/acet-20250414.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-054995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer